Influence of water soluble additives and HPMCP on drug release from surelease®-coated pellets containing tamsulosin hydrochloride

Archives of Pharmacal Research

Volumn 30, Issue 8, 2007, Pages 1008-1013

  Kim, Min Soo ^a   Kim, Jeong Soo ^a   Kang, Sun Ho ^a   Yoo, Yeon Hee ^a   Lee, Sibeum ^a   Park, Jeong Sook ^a   Woo, Jong Soo ^a,b   Hwang, Sung Joo ^a  

^a Chungnam National University   (South Korea)

^b Hanmi Pharmaceutical Co Ltd   (South Korea)

Author keywords

Drug release; HPMC; HPMCP; Mannitol; PEG 4000; Surelease

Indexed keywords

CELLULOSE; DRUG DERIVATIVE; ETHYL CELLULOSE; EXCIPIENT; HYDROXYPROPYLMETHYLCELLULOSE PHTHALATE; METHYLCELLULOSE; SULFONAMIDE; TAMSULOSIN; WATER;

ARTICLE; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG FORMULATION; DRUG IMPLANT; SOLUBILITY; TIME;

CELLULOSE; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG IMPLANTS; EXCIPIENTS; METHYLCELLULOSE; SOLUBILITY; SULFONAMIDES; TIME FACTORS; WATER;

EID: 34548794897     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02993970     Document Type: Article

References (23)

1. Appel, L. and Zentner, G. M., Use of modified ethylcellulose lattices for microporous coating of osmotic tablets. Pharm. Res., 8, 603-604 (1991).
2. Bodmeier, R. and Paeratakul, O., The effect of curing on drug release and morphological properties of ethylcellulose pseudolatex-coated beads. Drug Dev. Ind. Pharm., 20, 1517-1533 (1994).
3. Chan, L. W., Ong, K. T., and Heng, W. S., Novel film modifiers to alter the physical properties of composite ethylcellulose films. Pharm. Res., 22, 476-489 (2005).
4. Colorcon. Surelease®. Technical literature. http://www.colorcon.com/ pharma/mod_rel/surelease/lit/product_data/prod_info_19040. pdf (accessed 1 September 2006).
5. FDA, Guidance for industry, dissolution testing of immediate release solid oral dosage forms, Food & Drug Administration, Rockville, MD, August, 1997.
6. Heinämäki, J. T., Colarte, A. I., Nordström., A. J., and Yliruusi, J. K., Comparative evaluation of ammoniated aqueous and organic-solvent-based cellulose ester enteric coating systems: a study on free films. Int. J. Pharm., 109, 9-16 (1994).
7. Jenquin, M. R., Sarabia, R. E., Liebowitz, S. M. and McGinity, J. W., Relationship of film properties to drug release from monolithic films containing adjuvants. J. Pharm. Sci., 81, 983-989 (1992).
8. Kim, M. S., Jun, S. W., Lee, S., Lee, T. W., Park, J. S., and Hwang, S. J., The influence of Surelease and sodium alginate on the in-vitro release of tamsulosin hydrochloride in pellet dosage form. J. Pharm. Pharmacol., 57, 735-742 (2005a).
9. Kim, M. S., Park, G. D., Jun, S. W., Lee, S., Park, J. S., and Hwang, S. J., Controlled release tamsulosin hydrochloride from alginate beads with waxy materials. J. Pharm. Pharmacol., 57, 1521-1528 (2005b).
10. Lecomte, F., Siepmann, J., Walther, M., MacRae, R. J., and Bodmeier, B., pH-Sensitive polymer blends used as coating materials to control drug release from spherical beads: elucidation of the underlying mass transport mechanisms. Pharm. Res., 22, 1120-1141 (2005).
11. Matsushima, H., Kamimura, H., Soeishi, Y., Watanabe, T., Higuchi, S., and Tsunoo, M., Pharmacokinetics and Plasma Protein Binding of Tamsulosin Hydrochloride in Rats, Dogs, and Humans. Drug Metab. Dispos., 26, 240-245 (1998).
12. Ozturk, A. G., Ozturk, S. S., Palsson, B. O., Wheatley, T. A., and Dressman J. B., Mechanism of release from pellets coated with an ethylcellulose-based film. J. Control. Release, 14, 203-213 (1990).
13. Rohera, B. D. and Parikh, N. H., Influence of type and level of water-soluble additives on drug release and surface and mechanical properties of Surelease films. Pharm. Dev. Technol., 7, 421-432 (2002).
14. Sadeghi, F., Ford, J. L., Rubinstein, M. H., and Rajabi-Siahboomi, A. R., Comparative study of drug release from pellets coated with HPMC or Surelease. Drug Dev. Ind. Pharm., 26, 651-660 (2000).
15. Sadeghi, F., Ford, J. L., Rubinstein, M. H., and Rajabi-Siahboomi, A. R., Study of drug release from pellets coated with Surelease containing hydroxypropylmethylcellulose. Drug Dev. Ind. Pharm., 27, 419-430 (2001).
16. Sadeghi, F., Ford, J. L., and Rajabi-Siahboomi, A., The influence of drug type on the release profiles from Surelease-coated pellets. Int. J. Pharm., 254, 123-135 (2003).
17. Semdé, R., Amighi, K., Devleeschouwer, M. J., and Moës, A. J., Effect of pectinolytic enzymes on the theophylline release from pellets coated with water insoluble polymers containing pectin HM or calcium pectinate. Int. J. Pharm., 197, 169-179 (2000).
18. Tang, L., Schwartz, J. B., Porter, S. C., Schnarre, R. L., and Wigent, R. J., Drug release from film-coated chlorpheniramine maleate nonpareil beads: effect of water-soluble polymer, coating level, and soluble core material. Pharm. Dev. Technol., 5, 383-390 (2000).
19. Wesseling, M. and Bodmeier, R., Drug release from beads coated with an aqueous colloidal ethylcellulose dispersion, Aquacoat® or an organic ethylcellulose solution. Eur. J. Pharm. Biopharm., 47, 33-38 (1999).
20. Wilde, M.I. and McTavish, D., Tamsulosin. A review of its pharmacological properties and therapeutic potential in the management of symptomatic benign prostatic hyperplasia. Drugs 52, 883-898 (1996).
21. Wu, S. H. W., Wyatt, D. M., and Adams, M. W., Chemistry and applications of cellulosic polymers for enteric coatings of solid dosage forms. In: McGinity, J. W. (ed.) Aqueous polymeric coatings for pharmaceutical dosage forms. Marcel Dekker, New York, pp. 385-418, (1997).
22. Yuen, K. H., Deshmukh, A. A., and Newton, J. M., Development and in-vitro evaluation of a multiparticulate sustained release theophylline formulation. Drug Dev. Ind. Pharm., 19, 855-874 (1993).
23. Yuksel, N., Kamk, A. E., and Baykara, T., Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methods. Int. J. Pharm., 209, 57-67 (2000).